Moreover, ALDH2 can enhance anthracycline sensitivity of RCC and activates the transcription of HNF4α (55), and HNF4α also increased the chemosensitivity of RCC cells to oxaliplatin and 5-FU (56). This evidence concerns the gene ALDH2 and renal cell carcinoma.